Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries REFILE-UPDATE 1-AstraZeneca ticks another box as U.S. approves severe asthma drug By: Reuters: Company News November 16, 2017 at 10:59 AM EST LONDON, Nov 15 (Reuters) - AstraZeneca has achieved another milestone in rebuilding its drug portfolio with U.S. approval of a drug for severe asthma as the company battles to put patent losses on older medicines behind it. Read More >> Related Stocks: Amgen Astrazeneca Plc ADR Gsk Plc ADR Teva Pharmaceutical Industries ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
REFILE-UPDATE 1-AstraZeneca ticks another box as U.S. approves severe asthma drug By: Reuters: Company News November 16, 2017 at 10:59 AM EST LONDON, Nov 15 (Reuters) - AstraZeneca has achieved another milestone in rebuilding its drug portfolio with U.S. approval of a drug for severe asthma as the company battles to put patent losses on older medicines behind it. Read More >> Related Stocks: Amgen Astrazeneca Plc ADR Gsk Plc ADR Teva Pharmaceutical Industries ADR